In April of 2019, LSPediA was selected by the FDA to participate in the FDA DSCSA Pilot Project Program, focusing on utilizing LSPediA’s OneScan Solution for Verification, Notification, and Interoperability….
Learn More
It’s been 14 months since the FDA advised manufacturers, wholesalers, and repackagers on Product Identifier (PI) requirements. You’ll remember that it came as a bit of a shock to most…
Droguería Betances is a major wholesale drug distributor based in Puerto Rico that handles prescription products, consumer goods, OTC products and more. Hear from Frank Rivera, VP of Operations and…
Is everybody ready to handle the DSCSA Verification Requirements going into effect next week? Despite the FDA enforcement delay on the requirement to verify saleable returned product, wholesale distributors are…
Following the FDA’s lead, LSPediA Tools Help Companies Meet Verification Mandates Keep DSCSA On Track The DSCSA lays out a 10-year serialization journey for the pharmaceutical industry. Dr. Connie Jung,…
The US FDA published a compliance policy guidance document on September 23, 2019, announcing a one-year enforcement discretion for the Wholesale Distributor Verification Requirement for Saleable Returned Drug Product. Despite…
The HDA held their annual forum on serialization last week in Washington DC—and LSPediA was proud to be a sponsor of the event. As anticipated, the HDA did another outstanding…
In the FDA compliance policy final guidance document published on September 23, 2019 , FDA specifically called out that “manufacturer[‘s] verification obligations” will be enforced. Here, we take you for…
The US FDA published a compliance policy final guidance document on September 23, 2019, announcing a one-year enforcement discretion for the Wholesale Distributor Verification Requirement for Saleable Returned Drug Product....
Learn More
Learn how LSPediA’s clients are preparing for the November 2019 enforcement date for DSCSA compliance by utilizing our OneScan Verification Router Service (VRS) Solution.